[HTML][HTML] Assistance et assurance dans la constitution du système de protection sociale française
D Renard - Genèses, 2020 - cairn.info
Les études comparatives classiques sur le développement des Étatsprovidence1 soulignent
un retard français dont les causes ne sont pas aisément identifiables et dans lequel l’…
un retard français dont les causes ne sont pas aisément identifiables et dans lequel l’…
[HTML][HTML] Une vieillesse républicaine? L'état et la protection sociale de la vieillesse de l'assistance aux assurances sociales (1880-1914)
D Renard - Sociétés contemporaines, 1992 - persee.fr
DIDIER RENARD At the end of the XlXth and at the beginning of the XXth century, in France,
the modes of a social protection of the old age evolved significantly. The conceptions of the …
the modes of a social protection of the old age evolved significantly. The conceptions of the …
[HTML][HTML] Assistance publique et bienfaisance privée, 1885-1914
D Renard - Politiques et management public, 1987 - persee.fr
Dans les dernières années du 19ème siècle et les premières années du 20ème, le secteur
de l'assistance se transforme profondément Une administration centrale est créée, une …
de l'assistance se transforme profondément Une administration centrale est créée, une …
[BOOK][B] Plurigaussian simulations in geosciences
M Armstrong, A Galli, H Beucher, G Loc'h, D Renard… - 2011 - books.google.com
Simulation is the fastest developing branch of geostatistics and simulating facies inside
reservoirs and orebodies is the most exciting part of this. Several methods have been developed …
reservoirs and orebodies is the most exciting part of this. Several methods have been developed …
The validation of surrogate endpoints in meta-analyses of randomized experiments
…, G Molenberghs, T Burzykowski, D Renard… - …, 2000 - academic.oup.com
The validation of surrogate endpoints has been studied by Prentice (1989). He presented a
definition as well as a set of criteria, which are equivalent only if the surrogate and true …
definition as well as a set of criteria, which are equivalent only if the surrogate and true …
Validation of surrogate end points in multiple randomized clinical trials with failure time end points
Before a surrogate end point can replace a final (true) end point in the evaluation of an
experimental treatment, it must be formally ‘validated’. The validation will typically require large …
experimental treatment, it must be formally ‘validated’. The validation will typically require large …
Antibiotic prescribing for acute cough: the effect of perceived patient demand
Background GPs decide whether or not to prescribe antibiotics for acute cough. Apart from
clinical signs and symptoms, non-medical reasons influence this decision as well. Aim To …
clinical signs and symptoms, non-medical reasons influence this decision as well. Aim To …
Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders
…, D Michelson, JL Ramsey, RJ Moore, D Renard… - Drug and alcohol …, 2008 - Elsevier
OBJECTIVE: Adults with attention-deficit/hyperactivity disorder (ADHD) have higher rates of
alcohol and drug use disorders than adults without ADHD. The study aim was to determine if …
alcohol and drug use disorders than adults without ADHD. The study aim was to determine if …
[HTML][HTML] Logiques politiques et logiques de programme d'action: la création des administrations sociales sous la III e République 1
D Renard* - Revue française des affaires sociales, 2001 - cairn.info
Une difficulté de l’analyse des politiques publiques est de comprendre comment s’articulent
dans la prise de décision les logiques de court terme propres à la vie politique et les …
dans la prise de décision les logiques de court terme propres à la vie politique et les …
Omalizumab decreases IgE production in patients with allergic (IgE‐mediated) asthma; PKPD analysis of a biomarker, total IgE
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Omalizumab is a humanized anti‐IgE
monoclonal antibody that binds and captures circulating IgE, preventing interaction with …
monoclonal antibody that binds and captures circulating IgE, preventing interaction with …